DFCI Logo
DFCI Logo

Direct Connect for Healthcare Navigators

    In this section

    Short placeholder heading

    Contact Dana-Farber 
    Direct Connect

    866-977-3262
    EMAIL
    direct-connect-health-care-mural-653x447.jpg

    Patient outcomes and climbing cancer costs are impacted by high misdiagnosis rates and variations in care. Through Direct Connect, Dana-Farber partners with healthcare navigators who are looking to identify the right specialists for their clients' unique oncology needs. As a teaching affiliate of Harvard Medical School, Dana-Farber trains and recruits some of the world's best and brightest physicians and researchers in every cancer specialty – including the most complex and rare.

    Finding the Right Cancer Specialist for Your Client's Care

    Dana-Farber Direct Connect is led by a highly experienced clinical lead and a staff of seasoned patient liaisons. This specialized team will help you identify the best expert for your client's unique needs, whether your client is seeking ongoing treatment or a second opinion at Dana-Farber.

    Once a specialist is identified, the Direct Connect team will support your client with scheduling, medical records collection, lodging, and other needs related to their visit.

    Why Choose Dana-Farber

    yawkey-building-at-night-2-794x176.jpg

    Dana-Farber is the #1 cancer hospital in New England as ranked by U.S. News & World Report, and the only cancer hospital in the U.S. to be ranked in the top 5 for both adult and pediatric oncology care.1

    As a teaching affiliate of Harvard Medical School, Dana-Farber trains and recruits some of the world's best and brightest physicians and researchers in every cancer specialty — including the most complex and rare. Our physicians and researchers have helped develop many of the very latest therapies, which means we can provide the latest and best care, sooner.

    When it comes to cancer, it matters where you start.

    • Dana-Farber, an Alliance Dedicated Cancer Center (ADCC), shows 10% better 1-year survival rates and 7% better 5-year survival rates when compared to community hospital settings.2
    • At any given time, we are conducting more than 1,100 clinical trials — granting access to the latest therapies sooner.
    • Groundbreaking research drives new treatment options. Dana-Farber receives twice as much in research grant funding from the National Institutes of Health than any other cancer center.
    • With a 97% patient satisfaction rate, Dana-Farber's personalized approach to cancer care is unmatched.

    Contact Direct Connect

    1Dana-Farber Cancer Institute is ranked by U.S. News & World Report in collaboration with its partners, Brigham and Women's Hospital, for adult cancer care, and Boston Children's Hospital, for pediatric cancer care.

    2Pfister DG, Rubin DM, Elkin EB, et al. Risk Adjusting Survival Outcomes in Hospitals That Treat Patients With Cancer Without Information on Cancer Stage. JAMA Oncol. 2015;1(9):1303–1310. doi:10.1001/jamaoncol.2015.3151